Literature DB >> 18723446

Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current.

Xiao Yan Qi1, Yung-Hsin Yeh, Ling Xiao, Brett Burstein, Ange Maguy, Denis Chartier, Louis R Villeneuve, Bianca J J M Brundel, Dobromir Dobrev, Stanley Nattel.   

Abstract

Atrial tachycardia (AT) downregulates L-type Ca(2+) current (I(CaL)) and causes atrial fibrillation-promoting electric remodeling. This study assessed potential underlying signal transduction. Cultured adult canine atrial cardiomyocytes were paced at 0, 1, or 3 Hz (P0, P1, P3) for up to 24 hours. Cellular tachypacing (P3) mimicked effects of in vivo AT: decreased I(CaL) and transient outward current (I(to)), unchanged I(CaT), I(Kr), and I(Ks), and reduced action potential duration (APD). I(CaL) was unchanged in P3 at 2 and 8 hours but decreased by 55+/-6% at 24 hours. Tachypacing caused Ca(2+)(i) accumulation in P3 cells at 2 to 8 hours, but, by 24 hours, Ca(2+)i returned to baseline. Ca(v)1.2 mRNA expression was not altered at 2 hours but decreased significantly at 8 and 24 hours (32+/-4% and 48+/-4%, respectively) and protein expression was decreased (47+/-8%) at 24 hours only. Suppressing Ca(2+)(i) increases during tachypacing with the I(CaL) blocker nimodipine or the Ca(2+) chelator BAPTA-AM prevented I(CaL) downregulation. Calcineurin activity increased in P3 at 2 and 8 hours, respectively, returning to baseline at 24 hours. Nuclear factor of activated T cells (NFAT) nuclear translocation was enhanced in P3 cells. Ca(2+)-dependent signaling was probed with inhibitors of Ca(2+)/calmodulin (W-7), calcineurin (FK-506), and NFAT (INCA6): each prevented I(CaL) downregulation. Significant APD reductions ( approximately 30%) at 24 hours in P3 cells were prevented by nimodipine, BAPTA-AM, W-7, or FK-506. Thus, rapid atrial cardiomyocyte activation causes Ca(2+) loading, which activates the Ca(2+)-dependent calmodulin-calcineurin-NFAT system to cause transcriptional downregulation of I(CaL), restoring Ca(2+)i to normal at the cost of APD reduction. These studies elucidate for the first time the molecular feedback mechanisms underlying arrhythmogenic AT remodeling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18723446     DOI: 10.1161/CIRCRESAHA.108.175463

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  67 in total

1.  G protein-gated IKACh channels as therapeutic targets for treatment of sick sinus syndrome and heart block.

Authors:  Pietro Mesirca; Isabelle Bidaud; François Briec; Stéphane Evain; Angelo G Torrente; Khai Le Quang; Anne-Laure Leoni; Matthias Baudot; Laurine Marger; Antony Chung You Chong; Joël Nargeot; Joerg Striessnig; Kevin Wickman; Flavien Charpentier; Matteo E Mangoni
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

Review 2.  Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective.

Authors:  Stanley Nattel; Jordi Heijman; Liping Zhou; Dobromir Dobrev
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

3.  Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model.

Authors:  Na Li; David Y Chiang; Sufen Wang; Qiongling Wang; Liang Sun; Niels Voigt; Jonathan L Respress; Sameer Ather; Darlene G Skapura; Valerie K Jordan; Frank T Horrigan; Wilhelm Schmitz; Frank U Müller; Miguel Valderrabano; Stanley Nattel; Dobromir Dobrev; Xander H T Wehrens
Journal:  Circulation       Date:  2014-01-07       Impact factor: 29.690

4.  NFAT-dependent excitation-transcription coupling in heart.

Authors:  Luis F Santana
Journal:  Circ Res       Date:  2008-09-26       Impact factor: 17.367

5.  Metabolite regulation of the mitochondrial calcium uniporter channel.

Authors:  Dhanendra Tomar; John W Elrod
Journal:  Cell Calcium       Date:  2020-09-11       Impact factor: 6.817

Review 6.  Cardiac adrenergic control and atrial fibrillation.

Authors:  Antony J Workman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-04       Impact factor: 3.000

7.  Dominant frequency increase rate predicts transition from paroxysmal to long-term persistent atrial fibrillation.

Authors:  Raphael P Martins; Kuljeet Kaur; Elliot Hwang; Rafael J Ramirez; B Cicero Willis; David Filgueiras-Rama; Steven R Ennis; Yoshio Takemoto; Daniela Ponce-Balbuena; Manuel Zarzoso; Ryan P O'Connell; Hassan Musa; Guadalupe Guerrero-Serna; Uma Mahesh R Avula; Michael F Swartz; Sandesh Bhushal; Makarand Deo; Sandeep V Pandit; Omer Berenfeld; José Jalife
Journal:  Circulation       Date:  2014-01-24       Impact factor: 29.690

Review 8.  Novel approaches for pharmacological management of atrial fibrillation.

Authors:  Joachim R Ehrlich; Stanley Nattel
Journal:  Drugs       Date:  2009       Impact factor: 9.546

9.  KChIP2 attenuates cardiac hypertrophy through regulation of Ito and intracellular calcium signaling.

Authors:  Hongwei Jin; Lahouaria Hadri; Julieta Palomeque; Charlotte Morel; Ioannis Karakikes; Roger Kaprielian; Roger Hajjar; Djamel Lebeche
Journal:  J Mol Cell Cardiol       Date:  2010-01-04       Impact factor: 5.000

Review 10.  Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target.

Authors:  Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-09-26       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.